Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies

被引:78
作者
Colantonio, Lisandro D. [1 ]
Bittner, Vera [2 ]
Reynolds, Kristi [4 ]
Levitan, Emily B. [1 ]
Rosenson, Robert S. [5 ]
Banach, Maciej [6 ]
Kent, Shia T. [1 ]
Derose, Stephen F. [4 ]
Zhou, Hui [4 ]
Safford, Monika M. [3 ]
Muntner, Paul [1 ]
机构
[1] Univ Alabama Birmingham, Dept Epidemiol, 1700 Univ Blvd,LHL 450, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, W Midlands, England
[3] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, W Midlands, England
[4] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA
[5] Icahn Sch Med Mt Sinai, Mt Sinai Heart, New York, NY 10029 USA
[6] Med Univ Lodz, Dept Hypertens, Lodz, Poland
基金
美国国家卫生研究院;
关键词
coronary disease; epidemiology; follow-up studies; lipids; DENSITY-LIPOPROTEIN-CHOLESTEROL; CARDIOVASCULAR RISK; PREVALENCE; PREVENTION; STROKE; TRENDS; ADULTS; MEN;
D O I
10.1161/CIRCULATIONAHA.115.011646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The use of statins increased among US adults with high coronary heart disease (CHD) risk after publication of the 2001 cholesterol treatment guidelines. Methods and Results We analyzed the association between lipids and CHD among 9578 REasons for Geographic And Racial Differences in Stroke (REGARDS) study participants and 346595 Kaiser Permanente Southern California (KPSC) members with baseline lipid measurements in 2003 to 2007. We performed the same analyses among 14590 Atherosclerosis Risk In Communities (ARIC) study participants with lipid measurements in 1987 to 1989. Analyses were restricted to blacks and whites 45 to 64 years of age without CHD who were not taking statins at baseline. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides were measured at baseline. Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and ratios of total to high-density lipoprotein cholesterol and triglycerides to high-density lipoprotein cholesterol were calculated. The prevalence of diabetes mellitus, history of stroke, and antihypertensive medication use increased at higher low-density lipoprotein cholesterol in ARIC but not in REGARDS or KPSC. Over 8.9 years of follow-up, 225 CHD events occurred in REGARDS, 6547 events in KPSC, and 583 events in ARIC. After multivariable adjustment, less favorable lipid levels were associated with higher hazard ratios for CHD in ARIC. These associations were attenuated in REGARDS and KPSC. For example, the hazard ratio associated with the highest versus lowest quartile of low-density lipoprotein cholesterol (146 versus 102 mg/dL) was 1.89 (95% confidence interval, 1.42-2.51) in ARIC, 1.25 (95% confidence interval, 0.81-1.92) in REGARDS, and 1.49 (95% confidence interval, 1.38-1.61) in KPSC. Conclusion The association between lipids and CHD in contemporary studies may be attenuated by the preferential use of statins by high-risk individuals.
引用
收藏
页码:256 / 264
页数:9
相关论文
共 34 条
[1]  
[Anonymous], 2013, KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
[2]   Prevalence of cardiovascular comorbidities and utilization of evidence-based treatment strategies among statin users in a Medicare and commercial health plan [J].
Aronow, Herbert D. ;
Dutro, Michael P. ;
Kuznik, Andreas ;
Cwengros, James .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) :205-213
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]   Illustrating bias due to conditioning on a collider [J].
Cole, Stephen R. ;
Platt, Robert W. ;
Schisterman, Enrique F. ;
Chu, Haitao ;
Westreich, Daniel ;
Richardson, David ;
Poole, Charles .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2010, 39 (02) :417-420
[5]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[6]  
Collins R, 2003, LANCET, V361, P2005
[7]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[8]   General cardiovascular risk profile for use in primary care - The Framingham Heart Study [J].
D'Agostino, Ralph B. ;
Vasan, Ramachandran S. ;
Pencina, Michael J. ;
Wolf, Philip A. ;
Cobain, Mark ;
Massaro, Joseph M. ;
Kannel, William B. .
CIRCULATION, 2008, 117 (06) :743-753
[9]   Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation [J].
D'Agostino, RB ;
Grundy, S ;
Sullivan, LM ;
Wilson, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :180-187
[10]   AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY - FRAMINGHAM STUDY [J].
DAWBER, TR ;
KANNEL, WB ;
LYELL, LP .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1963, 107 (02) :539-&